BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tasaki Y, Suzuki M, Katsushima K, Shinjo K, Iijima K, Murofushi Y, Naiki-Ito A, Hayashi K, Qiu C, Takahashi A, Tanaka Y, Kawaguchi T, Sugawara M, Kataoka T, Naito M, Miyata K, Kataoka K, Noda T, Gao W, Kataoka H, Takahashi S, Kimura K, Kondo Y. Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer. Cancer Res 2021;81:1654-66. [PMID: 33648930 DOI: 10.1158/0008-5472.CAN-20-3021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Maurya SK, Rehman AU, Zaidi MAA, Khan P, Gautam SK, Santamaria-barria JA, Siddiqui JA, Batra SK, Nasser MW. Epigenetic alterations fuel brain metastasis via regulating inflammatory cascade. Seminars in Cell & Developmental Biology 2022. [DOI: 10.1016/j.semcdb.2022.11.001] [Reference Citation Analysis]
2 Wang HQ, Qian CH, Guo ZY, Li PM, Qiu ZJ. Long noncoding RNA negative regulator of antiviral response contributes to pancreatic ductal adenocarcinoma progression via targeting miR-299-3p. World J Gastroenterol 2022; 28(35): 5141-5153 [DOI: 10.3748/wjg.v28.i35.5141] [Reference Citation Analysis]
3 Sano M, Akagi D, Naito M, Hoshina K, Miyata K, Kataoka K, Ishihara S. Systemic single administration of anti-inflammatory microRNA 146a-5p loaded in polymeric nanomedicines with active targetability attenuates neointimal hyperplasia by controlling inflammation in injured arteries in a rat model. FASEB J 2022;36:e22486. [PMID: 35929425 DOI: 10.1096/fj.202101481R] [Reference Citation Analysis]
4 Eptaminitaki GC, Stellas D, Bonavida B, Baritaki S. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability. Drug Resistance Updates 2022;65:100866. [DOI: 10.1016/j.drup.2022.100866] [Reference Citation Analysis]
5 Ma Y, Di Y, Li Q, Zhan Q, He X, Liu S, Zou H, Corpe C, Chen L, Wang J. LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer. Discov Oncol 2022;13:61. [PMID: 35819532 DOI: 10.1007/s12672-022-00522-0] [Reference Citation Analysis]
6 Sturm N, Ettrich TJ, Perkhofer L. The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy. Cancers (Basel) 2022;14:217. [PMID: 35008381 DOI: 10.3390/cancers14010217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Pucci P. Combination therapy and noncoding RNAs: a new era of cancer personalized medicine. Epigenomics 2021. [PMID: 34852634 DOI: 10.2217/epi-2021-0405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Chai Y, Liu S, Xie M. Interaction among long non‐coding RNA, micro‐RNA and mRNA in glioma. Ibrain 2021;7:141-145. [DOI: 10.1002/j.2769-2795.2021.tb00076.x] [Reference Citation Analysis]